- BioHarvest Sciences (BHSC) has closed the second tranche of its private placement of convertible notes
- The company expects the offering to close an additional tranche of up to $3 million by December 15, 2022
- Under the second tranche, the company issued notes in the principal amount of $2,612,742.28
- Vancouver-based BioHarvest Sciences Inc. (BHSC) is the developer and exclusive owner of proprietary and patent-protected BioFarming technology
- BioHarvest Sciences Inc. (BHSC) is up 10.53 per cent on the day, trading at C$0.315 per share at 2:45 pm ET
BioHarvest Sciences (BHSC) has closed the second tranche of its oversubscribed private placement of convertible notes.
The company expects the offering to close an additional tranche of up to $3 million by December 15, 2022.
Under the second tranche, the company has issued notes in the principal amount of $2,612,742.28. With the closing of this tranche, the total amount raised under the offering to date is $ 9,490,985.94.
All securities issued are subject to a four-month statutory hold period, expiring March 16, 2023.
Vancouver-based BioHarvest Sciences Inc. (BHSC) is the developer and exclusive owner of proprietary and patent-protected BioFarming technology.
BioHarvest Sciences Inc. (BHSC) is up 10.53 per cent on the day, trading at C$0.315 per share at 2:45 pm ET.
